This post was originally published on this site Aiming to both inspire the multiple myeloma community and raise money to accelerate treatments, members of Moving Mountains for Multiple Myeloma (MM4MM) recently traversed Iceland’s impressive landscape. The 14-member excursion included two patients plus caregivers, family members, myeloma specialists, and individuals from organizing partners. The MM4MM initiative is a…
This post was originally published on this site Fujifilm Medical Systems USA has expanded its breast cancer imaging toolbox by releasing a new tomosynthesis option for its ASPIRE Cristalle mammography technology, which improves accuracy of breast biopsy. The new Tomosynthesis Biopsy solution determines the three-dimensional coordinates of a suspicious lesion in the breast. According to…
This post was originally published on this site AC Immune is launching a Phase 1b/2a clinical trial to evaluate an investigational anti-tau vaccine called ACI-35.030 as a potential disease-modifying treatment for Alzheimer’s disease and other disorders characterized by the accumulation of tau protein. The presence of abnormal aggregates of beta-amyloid and tau proteins in the brain…
This post was originally published on this site Have you heard the saying, “Talking to yourself is OK as long as you don’t expect a response”? Most of us do it, and I believe that self-talk is particularly prevalent among caregivers. I am an audible self-talker, whispering declarations and questions to no one in particular.…
This post was originally published on this site Aravive‘s experimental treatment, AVB-500, in combination with chemotherapy appears to be more effective than chemotherapy alone at treating platinum-resistant ovarian cancer, preliminary results from a first group of patients taking part in a Phase 1b/2 trial show. The company will increase enrollment in this U.S. study to further…
This post was originally published on this site A new video series by the American Journal of Managed Care (AJMC) features experts discussing issues related to multiple myeloma treatment. Called “A Review of the Treatment for Multiple Myeloma,” the 14-part educational series is the AJMC’s latest panel discussion. “During this educational video series, our panel of experts, led…
This post was originally published on this site Treatment with the oral therapy cerdulatinib alone or in combination with Rituxan (rituximab) shows durable efficacy, including some complete responses, in patients with follicular lymphoma who failed prior medications, according to early results of a Phase 2a trial. The study, “Rapid and Durable Responses with the SYK/JAK…
This post was originally published on this site An upcoming Phase 2 trial will explore the safety and effectiveness of a combo therapy — Opdivo (nivolumab) and MTG201 – for the treatment of malignant pleural mesothelioma. The trial will soon be looking for participants who received prior chemotherapy. Mesothelioma is a rare type of cancer,…
This post was originally published on this site A new test — based on genetic markers of immune response and with potential to be assayed in tumor biopsies — holds promise for identifying patients with triple-negative breast cancer (TNBC) who are at lower risk of disease recurrence, and therefore would benefit from less aggressive treatments.…
This post was originally published on this site To foster the cognitive stimulation of its Alzheimer’s disease (AD) residents, an Arkansas senior living center collaborated with the University of Arkansas – Fort Smith (UAFS) to produce recreational 3D-printed items. A set of large-scale, lightweight, and colorful plastic nuts and bolts were made especially for those Methodist…
